Jackson Creek Investment Advisors LLC Haemonetics Corp Transaction History

Jackson Creek Investment Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$81.24 - $97.37 $6,336 - $7,594	-78 Reduced 0.69%	11,293 $934,000
Q1 2024 May 09, 2024	SELL	$71.24 - $85.35 $7,693 - $9,217	-108 Reduced 0.94%	11,371 $971,000
Q4 2023 Feb 05, 2024	SELL	$80.59 - $92.61 $967 - $1,111	-12 Reduced 0.1%	11,479 $982,000
Q3 2023 Nov 03, 2023	SELL	$82.56 - $93.49 $5,283 - $5,983	-64 Reduced 0.55%	11,491 $1.03 Million
Q2 2023 Aug 02, 2023	SELL	$80.84 - $89.45 $208,648 - $230,870	-2,581 Reduced 18.26%	11,555 $984,000
Q1 2023 May 02, 2023	BUY	$72.75 - $90.6 $109,561 - $136,443	1,506 Added 11.92%	14,136 $1.17 Million
Q4 2022 Feb 03, 2023	SELL	$73.85 - $86.14 $33,158 - $38,676	-449 Reduced 3.43%	12,630 $993,000
Q3 2022 Nov 09, 2022	BUY	$63.3 - $78.66 $827,900 - $1.03 Million	13,079 New	13,079 $968,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.